Clinical Trials in San Diego

Showing 3621-3640 of 12,589 trials

Pulsed Shortwave Therapy for Postoperative Analgesia

NCT05796583

Pulsed shortwave (radiofrequency) therapy is a possible method of pain control involving the application of electromagnetic energy (also termed pulsed electromagnetic fields). Food and Drug Administration-cleared devices have been in clinical use for over 70 years. For decades, available devices consisted of a large signal generator and bulky coil applicator that were not portable and produced significant electromagnetic interference, making them impractical for common use. However, small, lightweight, relatively inexpensive, noninvasive, Food and Drug Administration-cleared devices that function for 8 days are now available to treat acute and chronic pain, decrease inflammation and edema, and hasten wound healing and bone regeneration. Therefore, it has the potential to concurrently improve analgesia and decrease or even negate opioid requirements, only without the limitations of opioids and peripheral nerve blocks. The purpose of this study is to explore the possibility of treating acute postoperative pain with nonthermal, pulsed shortwave (radiofrequency) therapy, optimize the study protocol, and estimate the treatment effect.

Postoperative Pain, Acute

University of California, San Diego70 participantsStarted Apr 2023

San Diego, California, United States

Not Yet Recruiting< 1 mile

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

NCT06876571

This protocol describes the pivotal accuracy study for the IdentiClone Dx TRG Assay. The intent of the accuracy study is to demonstrate agreement between the results of the IC TRG Dx Assay and a predicate devise or assay on retrospective and residual de-identified DNA extracted from FFPE (Formalin Fixed Paraffin Embedded) samples from individuals with suspected T-Cell Lymphoproliferations. The predicate device will be the LymphoTrack Dx TRG (FR1/FR2/FR3) Assays - MiSeq (LT Dx TRG-CE-IVD), which is a CE-IVD assay with a similar intended use as the IC TRG Assay on the same sample type.

T-Cell Lymphoproliferative Disorder

Invivoscribe, Inc.250 participantsStarted Jun 2025

San Diego, California, United States • Hallbergmoos, Germany • Kawasaki-shi, Kanagawa, Japan

Pulsed Shortwave Therapy for Postoperative Analgesia

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

Find Trials by Condition in San Diego

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

Infant Mortality Reduction by the Mass Administration of Azithromycin

A Study of LY3561774 in Participants With Mixed Dyslipidemia

Brain Injury Rehabilitation Improving the Transition Experience